Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00357890 · ClinicalTrials.gov registry record · NA
Insulin Pump Therapy in Adolescents With Newly Diagnosed Type 1 Diabetes (T1D)
A NA study, sponsored by Nemours Children's Clinic.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT00357890 is a NA study that has completed, run by Nemours Children's Clinic. The registered enrollment target is 12 participants.
The verdict
NCT00357890, a NA study, has completed, sponsored by Nemours Children's Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
Within 4 weeks after diagnosis of type 1 diabetes, 10 subjects (pubertal males, 12-17 years old) will be randomized to either receive multiple daily injection (MDI) using Lantus insulin, or continuous subcutaneous insulin infusion (CSII; pump therapy). The study evaluates how these modes of therapy affect insulin sensitivity (measured by the euglycemic-hyperinsulinemic clamp studies and adiponectin concentration changes) and beta cell function (measured by mixed meal tolerance testing).
Interventions
- DEVICE Insulin pump therapy
- DRUG Multiple daily injections using insulin glargine + rapid acting analog
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2005-12 |
| Est. Completion | 2014-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00357890
The ClinicalTrials.gov registry entry for NCT00357890 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nemours Children's Clinic, which has 108 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Insulin pump therapy is the first listed.
NCT00357890 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00357890 about?
NCT00357890 is a clinical study titled "Insulin Pump Therapy in Adolescents With Newly Diagnosed Type 1 Diabetes (T1D)". Within 4 weeks after diagnosis of type 1 diabetes, 10 subjects (pubertal males, 12-17 years old) will be randomized to either receive multiple daily injection (MDI) using Lantus insulin, or continuous subcutaneous insulin infusion (CSII; pump therapy). The study evaluates how these modes of therapy ...
What is the current status of trial NCT00357890?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2005-12. Estimated completion is 2014-10.
What interventions are being tested in trial NCT00357890?
The interventions under investigation include: Insulin pump therapy (DEVICE), Multiple daily injections using insulin glargine + rapid acting analog (DRUG).
Who is sponsoring clinical trial NCT00357890?
This trial is sponsored by Nemours Children's Clinic, which has 108 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.